Empoli 10mg Tablet contains Empagliflozin as its active ingredient. It is an oral antidiabetic medication belonging to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors. Empagliflozin is used for the management of type 2 diabetes mellitus to improve glycemic control.
Ingredients:
- Empagliflozin (10mg): Empagliflozin works by inhibiting the SGLT2 transporter in the kidney, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting SGLT2, Empagliflozin promotes the excretion of glucose in the urine, thereby lowering blood sugar levels.
Uses:
Empoli 10mg Tablet is indicated for the treatment of type 2 diabetes mellitus. It helps control blood sugar levels in patients whose diabetes cannot be adequately managed with diet, exercise, or other antidiabetic medications.
Side Effects:
- Genital Yeast Infections: Some individuals may experience genital yeast infections, such as vaginal yeast infections or balanitis.
- Urinary Tract Infections: Urinary tract infections, including bladder infections and kidney infections, have been reported with the use of Empagliflozin.
- Hypoglycemia: The risk of hypoglycemia (low blood sugar levels) is low with Empagliflozin when used alone, but it may occur when used in combination with other antidiabetic medications.
- Dehydration: Empagliflozin may lead to dehydration, especially in elderly patients or those with renal impairment, due to its mechanism of action in promoting the excretion of glucose and water in the urine.
Precautions:
- Renal Impairment: Use with caution in patients with renal impairment, as Empagliflozin’s efficacy may be reduced in patients with severe renal impairment or end-stage renal disease.
- Urinary Tract Infections: Patients should be advised to maintain adequate hydration and practice good hygiene to reduce the risk of urinary tract infections.
- Hypotension: Empagliflozin may cause a decrease in blood pressure, especially in patients taking antihypertensive medications. Blood pressure should be monitored regularly, especially at the initiation of therapy.
- Hypoglycemia Risk: Patients should be educated about the signs and symptoms of hypoglycemia and instructed on appropriate measures to manage low blood sugar levels.
When Not to Use:
Empoli 10mg Tablet is contraindicated in patients with:
- Known hypersensitivity to Empagliflozin or any component of the tablet.
- Type 1 diabetes mellitus or diabetic ketoacidosis.
- Severe renal impairment (eGFR less than 30 mL/min/1.73 m²).
- End-stage renal disease, or patients on dialysis.
FAQ:
- How should Empoli 10mg Tablet be taken?
- Empoli 10mg Tablet is usually taken orally once daily, with or without food. The dosage may vary depending on the patient’s response to treatment and renal function.
- What should I do if I miss a dose of Empoli 10mg Tablet?
- If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. Patients should not double the dose to make up for a missed dose and should continue with the regular dosing schedule.
- Can Empoli 10mg Tablet cause interactions with other medications?
- Empagliflozin may interact with certain medications, such as diuretics, antihypertensive drugs, or medications that affect renal function. It is essential to inform the healthcare provider about all medications being taken to avoid potential interactions.
- Is Empoli 10mg Tablet safe for elderly patients?
- Empoli 10mg Tablet can be used in elderly patients with caution, as they may be more susceptible to the effects of dehydration and hypotension. The dosage may need adjustment based on renal function and other factors.
Reviews
There are no reviews yet.